Brief: Zymeworks And Royalty Pharma Enter Into $250 Million Royalty-Backed Note Financing
02/03/2026 14:04
March 2 (Reuters) - Royalty Pharma PLC RPRX.O: ZYMEWORKS AND ROYALTY PHARMA ENTER INTO $250 MILLION ROYALTY-BACKED NOTE FINANCING ZYMEWORKS INC - CO TO RETAIN 70% OF ZIIHERA ROYALTIES Source text: ID:nGNX7tKtn2 Further company coverage: RPRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zymeworks
See all newsUS STOCKS ON THE MOVE-Huron Consulting, RingCentral, Selective Insurance
U.S. STOCKS ON THE MOVE-Huron Consulting, Crown Castle, Bloom Energy
US STOCKS ON THE MOVE-Booz Allen Hamilton, SLB, Deckers Outdoor
US STOCKS ON THE MOVE-American Express, Gorman-Rupp, Moderna
Zymeworks gains on up to $813 million Roche licensing deal for lung cancer drug